DUPUYTREN’S DISEASE LICENSE AGREEMENTDupuytren’s Disease License Agreement • November 28th, 2006 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This DUPUYTREN’S DISEASE LICENSE AGREEMENT (the “Agreement”), effective as of November 21, 2006 (the “Effective Date”), is entered into by and between BioSpecifics Technologies Corp., a corporation organized and existing under the laws of Delaware (“BTC”), and the Research Foundation of the State University of New York for and on behalf of Stony Brook University, a nonprofit, educational corporation organized and existing under the laws of New York (the “Research Foundation”). BTC and the Research Foundation shall sometimes be referred to herein individually as a “Party” and collectively as “Parties.”
